Switch to:
More From Other Websites
Articles of Association for Genmab A/S May 02 2016
Genmab Announces Daratumumab Data to be Presented at 2016 ASCO Annual Meeting Apr 20 2016
Genmab Updates Financial Guidance for 2016 Apr 20 2016
ETF’s with exposure to Gencor Industries, Inc. : April 8, 2016 Apr 08 2016
Gencor Industries, Inc. :GENC-US: Earnings Analysis: Q1, 2016 By the Numbers Apr 07 2016
Patent Infringement Lawsuit Filed Against Genmab and Janssen in the United States Regarding... Apr 04 2016
CHMP Issues Positive Opinion Recommending DARZALEX® (daratumumab) for Relapsed and Refractory... Apr 01 2016
Genmab Announces Positive Interim Result in Phase III Castor Study of Daratumumab in Relapsed or... Mar 30 2016
Genmab Announces Studies of Daratumumab in Combination with Atezolizumab in a Solid Tumor and... Mar 21 2016
GENCOR INDUSTRIES INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Mar 10 2016
GENCOR INDUSTRIES INC Financials Feb 13 2016
Gencor posts 1Q profit Feb 10 2016
Gencor posts 1Q profit Feb 10 2016
Gencor Releases First Quarter Fiscal 2016 Results Feb 10 2016
GENCOR INDUSTRIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 10 2016
GENCOR INDUSTRIES INC Files SEC form 10-Q, Quarterly Report Feb 10 2016
Genmab Announces U.S. FDA Approval of Arzerra® (ofatumumab) as Extended Treatment for Recurrent or... Jan 19 2016
Daratumumab Data Published in The Lancet Shows Encouraging Efficacy in Heavily Pretreated and... Jan 07 2016
Genmab Achieves $3 Million Milestone in DuoBody Platform Collaboration with Janssen Dec 21 2015
Genmab Announces Completion of Agreement to Transfer Remaining Ofatumumab Rights Dec 21 2015


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK